What one share of Atea Pharmaceuticals holds
We are a late-stage clinical biopharmaceutical company leveraging our deep understanding of antiviral drug development, medicinal chemistry, biochemistry and virology to discover, develop and commercialize novel, orally administered antivirals to treat serious viral diseases.
Atea Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$2.10 |
|---|---|
| Cash and investments | $0.95 |
| Book value | $2.55 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2018 | — | −$0.90 | $0.00 | −$0.79 | — | −$3.60 |
| 2019 | — | −$1.39 | $0.00 | −$1.27 | — | −$4.91 |
| 2020 | $2.25 | −$0.51 | $0.00 | $13.74 | — | — |
| 2021 | $3.98 | $1.37 | $0.00 | −$0.99 | — | $8.54 |
| 2022 | — | −$1.39 | $0.02 | −$1.48 | — | $7.69 |
| 2023 | — | −$1.63 | — | — | — | $6.65 |
| 2024 | — | −$2.00 | — | — | — | $5.20 |
| 2025 | — | −$1.94 | — | — | — | $3.53 |
Common questions about Atea Pharmaceuticals
How much does one share of Atea Pharmaceuticals earn?
Over the last 12 months, Atea Pharmaceuticals lost $2.10 for each share.
Does Atea Pharmaceuticals pay a dividend?
Atea Pharmaceuticals didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Atea Pharmaceuticals’s book value per share?
Atea Pharmaceuticals’s book value is $2.55 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Atea Pharmaceuticals have?
Each share of Atea Pharmaceuticals has $0.95 of cash and investments, as of June 30, 2026.
Has Atea Pharmaceuticals bought back shares?
Atea Pharmaceuticals’s share count rose about 712% from 2018 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.